APPLICATION OF DEXSTRANSULFATE, HAVING A MEDIUM MOLECULAR MASS, LESS THAN 10,000 YES, FOR INDUCING ANGIOGENESIS IN THE SUBJECT

摘要

The present embodiments of the invention relate to the use of dextran sulfate, having an average molecular weight of less than 10,000 Da, for inducing angiogenesis in a subject and for increasing blood flow in a subject suffering from ischemia.